Tezosentan in Acute Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

735

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Acute Heart FailureAcute Decompensation of Chronic Heart FailureNew Onset of Heart Failure
Interventions
DRUG

tezosentan

tezosentan delivered i.v. at 20 mL/h (5 mg/h) for 30 min followed by 4ML/h (1 mg/h) for 23.5 to 71.5 h (24 to 72 h in total)

Trial Locations (35)

Unknown

University of Alabama-Birmingham, Birmingham

Advanced Heart Failure and Transplant Service, Palo Alto VA Health Care System, Cardiology Section, Palo Alto

Denver VAMC, Denver

The Heart Hospital at Alledgheny General, Division of Cardiology, Pittsburgh

Veterans Affairs Medical Center, Houston

Tyler Cardiovascular Consultants, Tyler

Danville Medical Center, Danville

Medical Associates, Bellebue, Bellevue

AKH University of Vienna, Abt. Medizinische Kardiologie, Vienna

Roskilde Amt Sygehus, Roskilde

Hopital Ambroise Pare, Service de Cardiologie, Boulogne

Heart Failure clinic C.H. Dubos, Pontoise

Hopitaux Universitaires de Strasbourg, Hopital Hautepierre, Strasbourg

CHU Rangueil, Cardiologie A, Toulouse

Medizinische Klinik I, Universitatsklinikum Aachen, Aachen

Campus Virchow-Klinikum, Medizinishe Klinik mit Schwerpunkt Kardiologie, Berlin

Georg-August-Universitat Gottingen, Zentrum fur Innere Med, Göttingen

Dept. of Cardiology, University of Athens, Alexandra Hospital, Athens

Barzilai Hospital, Ashkelon

Carmel Medical Center, Haifa

Wolfson Medical Center, Holon

Hadassah Hospital, Jerusalem

Nazareth Hospital EMMS, Nazareth

Assaf-Harofeh Medical Center, Ẕerifin

Klinika Kardiologii i Chorob Wewnetrznych, Samodzielny Publiczny Szpital, Bydgoszcz

Klinika Chorob Serca, Akademia Medyczna w Gdansku, Gdansk

I Klinika Kardiolgii, Collegium Medicum UJ, Krakow

Institute of Cardiology College, College of Medicine of Jagellonian University, Krakow

Kategra I Klinika Kardiolgii AM, Wroclaw

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne

Cardio Centro Ticino, Servizio Cardiovasculare, Lugano

University Hospital Zurich, Zurich

Glasgow Royal Infirmary, Glasgow

Hull Royal Infirmary, Hull

Scunthorpe General Hospital, Scunthorpe

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY